Stoke Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.

CEO

Ian Frederick Smith

CEOIan Frederick Smith

Employees

128

Employees128

Headquarters

Bedford, Massachusetts

HeadquartersBedford, Massachusetts

Founded

2014

Founded2014

Employees

128

Employees128

STOK Key Statistics

Market cap

1.07B

Market cap1.07B

Price-Earnings ratio

23.15

Price-Earnings ratio23.15

Dividend yield

—

Dividend yield—

Average volume

1.25M

Average volume1.25M

High today

$19.91

High today$19.91

Low today

$19.13

Low today$19.13

Open price

$19.73

Open price$19.73

Volume

1.12M

Volume1.12M

52 Week high

$19.91

52 Week high$19.91

52 Week low

$5.35

52 Week low$5.35

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

9.1%

Sell

People also own

Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.